News

Knowlege Transfer with SoftWert

April 4, 2024

The BMBF (Federal Ministry for Ecucation and Research) funded SoftWert project offers transfer agents a toolkit of methods for the commercial and non-commercial exploitation of scientific software. This toolkit addresses the tangible need of scientific organizations to establish suitable procedures for these exploitation processes.

In the project of the Deutsches Elektronen-Synchrotron (DESY), the Helmholtz Centre Potsdam - German Research Centre for Geosciences (GFZ) and the German Center for Neurodegenerative Diseases (DZNE) in cooperation with Saarland University and Atrineo AG, a transfer consulting and support provider, the project partners share their experiences, best practices and newly tested methods in an illustrative booklet and via the website softwert.org (only GER).

DLR spin-off Lumoview receives 2.5 million euro EIC Accelerator Grant

March 11, 2024

As one of 42 funded projects from a pool of 1083 applicants, the spin-off of the German Aerospace Center (DLR) was awarded funding from the European Innovation Council. With its EIC Accelerator Grant, the young company aims to expand further and make it easier for property owners to operate their buildings more energy-efficiently.

Lumoview Building Analytics GmbH manufactures measuring devices that can be used to measure and analyze individual rooms and entire buildings quickly and cost-effectively.

Website of Lumoview →

TherVacB - Helmholtz Munich's therapeutic vaccine against chronic hepatitis B enters the clinical phase

February 29, 2024

The therapeutic vaccine TherVacB against chronic hepatitis B, a liver disease that can lead to tissue damage and even liver cancer, developed under the leadership of Helmholtz Munich in the framework of a Helmholtz Proof-of-Concept Project, has reached the first clinical phase. Current treatments for chronic hepatitis B can reduce the viral load, but do not provide a cure for the approximately 296 million people infected worldwide.

The newly developed vaccine now has the potential to do just that: initial safety and immunogenicity tests have already been carried out in a phase 1a study on healthy volunteers in collaboration with the LMU Klinikum München and the University Medical Center Hamburg-Eppendorf. In a phase 1b/2a first-in-patient study, the safety and efficacy in patients with chronic hepatitis B will soon be tested in several EU countries.

Helmholtz Munich Press Release→

Three Helmholtz Enterprise Alumni Spin off from GFZ in 2023

February 2, 2024

In 2023, the Helmholtz Centre Potsdam - German Research Centre for Geosciences (GFZ) recorded three new spin-offs, all of which are alumni of the Helmholtz Enterprise spin-off program: GreenGate Genomics, FOMON and fluxtec. The spin-offs underline the continuing positive trend towards start-ups at the GFZ, which has produced a total of 13 successful founding teams in the last six years. The spin-offs use technologies and patents developed at the GFZ and receive support from the GFZ Transfer Office.

GFZ press release with further information on the spin-offs →

Networking Event for Helmholtz Enterprise Spin-off Teams in Berlin

January 25, 2024

12 spin-off teams currently being funded by our Helmholtz Enterprise spin-off program from seven Helmholtz Centres met in Berlin on 23 January. They used the networking event to share their successes, challenges and best practices that have shaped the course of their spin-off projects so far. The event additionally gave them the opportunity to refine their sustainability strategies under the guidance of experts from ImpactNexus GmbH.